Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05613608
PHASE2/PHASE3

Alcohol Use Disorder and Cannabidiol

Sponsor: University of Colorado, Denver

View on ClinicalTrials.gov

Summary

This is a double-blind, placebo-controlled, parallel group study designed to assess the efficacy of full spectrum CBD and broad spectrum CBD, compared to a placebo control (PC), to reduce drinking in participants with alcohol use disorder. If eligible for the study, subjects will be randomized to receive one of the conditions for 12 weeks.

Official title: Alcohol Use Disorder and Cannabis: Testing Novel Harm Reduction Strategies

Key Details

Gender

All

Age Range

21 Years - Any

Study Type

INTERVENTIONAL

Enrollment

180

Start Date

2023-04-30

Completion Date

2027-04

Last Updated

2024-10-01

Healthy Volunteers

No

Interventions

DRUG

Cannabidiol

The current study will directly test the hypothesis that a moderate dose of CBD leads to a reduction in alcohol consumption, alcohol craving, peripheral markers of inflammation, and anxiety.

DRUG

Placebo

Placebo arm.

Locations (1)

University of Colorado Anschutz

Aurora, Colorado, United States